Request for the Technical Review of 3 Draft Immediately Dangerous to Life or Health (IDLH) Value Profiles, 26685-26686 [2018-12364]
Download as PDF
<![CDATA[
Federal Register / Vol. 83, No. 111 / Friday, June 8, 2018 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Agency for Healthcare Research and
Quality
Agency Information Collection
Activities: Proposed Collection;
Comment Request; Correction
Agency for Healthcare Research
and Quality (AHRQ), Department of
Health and Human Services.
ACTION: Notice, correction.
AGENCY:
The Agency for Healthcare
Research and Quality published a
correction document in the Federal
Register of May 29, 2018 regarding
AHRQ Seeking Input on Library of
Patient-Centered Outcomes Research
Resources. This document contained an
error in the email address where
comments should be submitted.
FOR FURTHER INFORMATION CONTACT:
Carla Ladner at 301–427–1205 or
AHRQ_Fed_Register@ahrq.hhs.gov.
SUMMARY:
Correction
In the correction to the Federal
Register of May 29, 2018, in FR Doc
2018–11472, on page 1, line 29, correct
the caption under ADDRESSES to read:
Electronic responses are preferred and
should be sent to: PCORResources@
ahrq.hhs.gov.
Dated: June 4, 2018.
Carla M. Ladner,
Correspondence Analyst/Federal Register
Liaison—AHRQ.
[FR Doc. 2018–12312 Filed 6–7–18; 8:45 am]
BILLING CODE 4160–90–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Agency for Healthcare Research and
Quality
Agency Information Collection
Activities: Proposed Collection;
National Advisory Council for
Healthcare Research and Quality:
Request for Nominations for Public
Members
Agency for Healthcare Research
and Quality (AHRQ), HHS.
ACTION: Notice of request for
nominations for public members.
amozie on DSK3GDR082PROD with NOTICES1
AGENCY:
The Council is to advise the
Secretary of HHS (Secretary) and the
Director of the Agency for Healthcare
Research and Quality (AHRQ) on
matters related to activities of the
Agency to carry out its mission. AHRQ’s
mission is to produce evidence to make
health care safer, higher quality, more
SUMMARY:
VerDate Sep<11>2014
16:53 Jun 07, 2018
Jkt 241001
accessible, equitable, and affordable,
and to work within the U.S. Department
of Health and Human Services and with
other partners to make sure that the
evidence is understood and used.
DATES: Nominations should be received
on or before 60 days after date of
publication.
Nominations should be sent
to Jaime Zimmerman AHRQ, 5600
Fishers Lane, 06E37A, Rockville,
Maryland 20857. Nominations may also
be emailed to
NationalAdvisoryCouncil@ahrq.hhs.gov.
FOR FURTHER INFORMATION CONTACT:
Jaime Zimmerman, AHRQ, at (301) 427–
1456.
SUPPLEMENTARY INFORMATION: 42 U.S.C.
299c establishes a National Advisory
Council for Healthcare Research and
Quality (the Council). Seven current
members’ terms will expire in
November 2018. To fill these positions,
we are seeking individuals who are
distinguished in: (1) The conduct of
research, demonstration projects, and
evaluations with respect to health care;
(2) the fields of health care quality
research or health care improvement; (3)
the practice of medicine; (4) other
health professions; (5) representing the
private health care sector (including
health plans, providers, and purchasers)
or administrators of health care delivery
systems; (6) the fields of health care
economics, information systems, law,
ethics, business, or public policy; and,
(7) representing the interests of patients
and consumers of health care. 42 U.S.C.
299c(c)(2).
Individuals are particularly sought
with experience and success in
activities specified in the summary
above. 42 U.S.C. 299c provides that the
Secretary shall appoint to the National
Advisory Council for Healthcare
Research and Quality twenty one
appropriately qualified individuals. At
least seventeen members shall be
representatives of the public and at least
one member shall be a specialist in the
rural aspects of one or more of the
professions or fields listed in the above
summary. In addition, the Secretary
designates, as ex officio members,
representatives from other Federal
agencies, principally agencies that
conduct or support health care research,
as well as Federal officials the Secretary
may consider appropriate. 42 U.S.C.
299c(c)(3). Consistent with revised
guidance regarding the ban on lobbyists
serving as members of advisory boards
and commissions, AHRQ will accept
nominations for Federally-registered
lobbyists to serve on the Council in a
representative capacity.
ADDRESSES:
PO 00000
Frm 00045
Fmt 4703
Sfmt 4703
26685
The Council meets in the Washington,
DC, metropolitan area, generally in
Rockville, Maryland, approximately
three times a year to provide broad
guidance to the Secretary and AHRQ’s
Director on the direction of and
programs undertaken by AHRQ.
Seven individuals will be selected by
the Secretary to serve on the Council
beginning with the meeting in the
spring of 2019. Members generally serve
3-year terms. Appointments are
staggered to permit an orderly rotation
of membership.
Interested persons may nominate one
or more qualified persons for
membership on the Council. Selfnominations are accepted. Nominations
shall include: (1) A copy of the
nominee’s resume or curriculum vitae;
and (2) a statement that the nominee is
willing to serve as a member of the
Council. Selected candidates will be
asked to provide detailed information
concerning their financial interests,
consultant positions and research grants
and contracts, to permit evaluation of
possible sources of conflict of interest.
Please note that once a candidate is
nominated, AHRQ may consider that
nomination for future positions on the
Council.
The Department seeks a broad
geographic representation. In addition,
AHRQ conducts and supports research
concerning priority populations, which
include: Low-income groups; minority
groups; women; children; the elderly;
and individuals with special health care
needs, including individuals with
disabilities and individuals who need
chronic care or end-of-life health care.
See 42 U.S.C. 299(c). Nominations of
persons with expertise in health care for
these priority populations are
encouraged.
Francis D. Chesley, Jr.,
Acting Deputy Director.
[FR Doc. 2018–12361 Filed 6–7–18; 8:45 am]
BILLING CODE 4160–90–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[Docket Number CDC–2018–0055, NIOSH
156–D]
Request for the Technical Review of 3
Draft Immediately Dangerous to Life or
Health (IDLH) Value Profiles
National Institute for
Occupational Safety and Health
(NIOSH) of the Centers for Disease
Control and Prevention (CDC),
AGENCY:
E:\FR\FM\08JNN1.SGM
08JNN1
26686
Federal Register / Vol. 83, No. 111 / Friday, June 8, 2018 / Notices
Department of Health and Human
Services (HHS).
ACTION:
Request for comments.
The National Institute for
Occupational Safety and Health of the
Centers for Disease Control and
Prevention announces the availability of
three (3) draft Immediately Dangerous to
Life or Health (IDLH) Value Profiles
now available for public comment for
the chemicals bromine trifluoride,
chlorine trifluoride, and ethylene
dibromide. To view the notice and
related materials, visit
www.regulations.gov and enter CDC–
2018–0055 in the search field and click
‘‘Search.’’
SUMMARY:
Table of Contents
•
•
•
•
•
•
Dates
Addresses
For Further Information Contact
Supplementary Information
Background
Reference
Electronic or written comments
must be received by August 7, 2018.
DATES:
You may submit comments,
identified by CDC–2018–0055 and
docket number NIOSH 156–D, by any of
the following methods:
ADDRESSES:
• Federal eRulemaking Portal: https://
www.regulations.gov. Follow the
instructions for submitting comments.
• Mail: National Institute for
Occupational Safety and Health, NIOSH
Docket Office, 1090 Tusculum Avenue,
MS C–34, Cincinnati, Ohio 45226–1998.
Instructions: All information received
in response to this notice must include
the agency name and docket number
[CDC–2018–0055; NIOSH 156–D]. All
relevant comments received will be
posted without change to
www.regulations.gov, including any
personal information provided. For
access to the docket to read background
documents or comments received, go to
www.regulations.gov. All information
received in response to this notice will
also be available for public examination
and copying at the NIOSH Docket
Office, 1150 Tusculum Avenue, Room
155, Cincinnati, OH 45226–1998.
FOR FURTHER INFORMATION CONTACT:
R. Todd Niemeier, NIOSH, Robert A.
Taft Laboratories, MS–C32, 1090
Tusculum, Cincinnati, OH 45226,
telephone (513) 533–8166 (not a toll free
number).
SUPPLEMENTARY INFORMATION: NIOSH is
requesting technical reviews of the three
(3) draft IDLH Value Profiles. To
facilitate the review of these documents,
NIOSH requests that the following
questions be taken into consideration:
1. Does this document clearly outline
the health hazards associated with acute
(or short-term) exposures to the
chemical? If not, what specific
information is missing from the
document?
2. Are the rationale and logic behind
the derivation of an IDLH value for a
specific chemical clearly explained? If
not, what specific information is needed
to clarify the basis of the IDLH value?
3. Are the conclusions supported by
the data?
4. Are the tables clear and
appropriate?
5. Is the document organized
appropriately? If not, what
improvements are needed?
6. Are you aware of any scientific data
reported in governmental publications,
databases, peer-reviewed journals, or
other sources that should be included
within this document?
NIOSH seeks comments on 3 draft
IDLH values and IDLH Value Profiles.
The draft IDLH Value Profiles were
developed to provide the scientific
rationale behind derivation of IDLH
values for the following chemicals:
Document No.
Chemical
C–01 ........................................................................................
C–02 ........................................................................................
C–03 ........................................................................................
Bromine Trifluoride ..................................................................
Chlorine Trifluoride ..................................................................
Ethylene Dibromide .................................................................
amozie on DSK3GDR082PROD with NOTICES1
Each IDLH Value Profile provides a
detailed summary of the health hazards
of acute exposures to high airborne
concentrations and the rationale for the
proposed IDLH value with the
chemical(s) of interest.
Background: In 2013, NIOSH
published Current Intelligence Bulletin
(CIB) 66—Derivation of Immediately
Dangerous to Life or Health (IDLH)
Values [NIOSH 2013]. Since the
establishment of the IDLH values in the
1970s, NIOSH has continued to review
available scientific data to improve the
protocol used to derive acute exposure
guidelines, in addition to the chemicalspecific IDLH values. The information
presented in this CIB represents the
most recent update of the scientific
rationale and the methodology (hereby
referred to as the IDLH methodology)
used to derive IDLH values. The
primary objectives of this document are
to:
1. Provide a brief history of the
development of IDLH values.
VerDate Sep<11>2014
16:53 Jun 07, 2018
Jkt 241001
2. Update the scientific bases and risk
assessment methodology used to derive
IDLH values from quality data.
3. Provide transparency behind the
rationale and derivation process for
IDLH values.
4. Demonstrate how scientifically
credible IDLH values can be derived
from available data resources.
The IDLH methodology is based on a
weight-of-evidence approach that
applies scientific judgment for critical
evaluation of the quality and
consistency of scientific data and in
extrapolation from the available data to
the IDLH value. The weight-of-evidence
approach refers to critical examination
of all available data from diverse lines
of evidence and the derivation of a
scientific interpretation on the basis of
the collective body of data, including its
relevance, quality, and reported results.
Conceptually, the derivation process for
IDLH values is similar to that used in
other risk-assessment applications,
including these steps:
1. Hazard characterization.
PO 00000
Frm 00046
Fmt 4703
Sfmt 4703
CAS No.
(7787–71–5)
(7790–91–2)
(106–93–4)
2. Identification of critical adverse
effects.
3. Identification of a POD.
4. Application of appropriate UFs,
based on the study and POD.
5. Determination of the final risk
value.
Reference
NIOSH [2013]. Current Intelligence Bulletin
66: Derivation of immediately dangerous
to life or health (IDLH) values.
Cincinnati, OH: U.S. Department of
Health and Human Services, Centers for
Disease Control and Prevention, National
Institute for Occupational Safety and
Health, DHHS (NIOSH) Publication
2014–100.
Dated: June 5, 2018.
John J. Howard,
Director, National Institute for Occupational
Safety and Health, Centers for Disease Control
and Prevention.
[FR Doc. 2018–12364 Filed 6–7–18; 8:45 am]
BILLING CODE 4163–19–P
E:\FR\FM\08JNN1.SGM
08JNN1
]]>Agencies
[Federal Register Volume 83, Number 111 (Friday, June 8, 2018)]
[Notices]
[Pages 26685-26686]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-12364]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[Docket Number CDC-2018-0055, NIOSH 156-D]
Request for the Technical Review of 3 Draft Immediately Dangerous
to Life or Health (IDLH) Value Profiles
AGENCY: National Institute for Occupational Safety and Health (NIOSH)
of the Centers for Disease Control and Prevention (CDC),
[[Page 26686]]
Department of Health and Human Services (HHS).
ACTION: Request for comments.
-----------------------------------------------------------------------
SUMMARY: The National Institute for Occupational Safety and Health of
the Centers for Disease Control and Prevention announces the
availability of three (3) draft Immediately Dangerous to Life or Health
(IDLH) Value Profiles now available for public comment for the
chemicals bromine trifluoride, chlorine trifluoride, and ethylene
dibromide. To view the notice and related materials, visit
www.regulations.gov and enter CDC-2018-0055 in the search field and
click ``Search.''
Table of Contents
Dates
Addresses
For Further Information Contact
Supplementary Information
Background
Reference
DATES: Electronic or written comments must be received by August 7,
2018.
ADDRESSES: You may submit comments, identified by CDC-2018-0055 and
docket number NIOSH 156-D, by any of the following methods:
Federal eRulemaking Portal: https://www.regulations.gov.
Follow the instructions for submitting comments.
Mail: National Institute for Occupational Safety and
Health, NIOSH Docket Office, 1090 Tusculum Avenue, MS C-34, Cincinnati,
Ohio 45226-1998.
Instructions: All information received in response to this notice
must include the agency name and docket number [CDC-2018-0055; NIOSH
156-D]. All relevant comments received will be posted without change to
www.regulations.gov, including any personal information provided. For
access to the docket to read background documents or comments received,
go to www.regulations.gov. All information received in response to this
notice will also be available for public examination and copying at the
NIOSH Docket Office, 1150 Tusculum Avenue, Room 155, Cincinnati, OH
45226-1998.
FOR FURTHER INFORMATION CONTACT: R. Todd Niemeier, NIOSH, Robert A.
Taft Laboratories, MS-C32, 1090 Tusculum, Cincinnati, OH 45226,
telephone (513) 533-8166 (not a toll free number).
SUPPLEMENTARY INFORMATION: NIOSH is requesting technical reviews of the
three (3) draft IDLH Value Profiles. To facilitate the review of these
documents, NIOSH requests that the following questions be taken into
consideration:
1. Does this document clearly outline the health hazards associated
with acute (or short-term) exposures to the chemical? If not, what
specific information is missing from the document?
2. Are the rationale and logic behind the derivation of an IDLH
value for a specific chemical clearly explained? If not, what specific
information is needed to clarify the basis of the IDLH value?
3. Are the conclusions supported by the data?
4. Are the tables clear and appropriate?
5. Is the document organized appropriately? If not, what
improvements are needed?
6. Are you aware of any scientific data reported in governmental
publications, databases, peer-reviewed journals, or other sources that
should be included within this document?
NIOSH seeks comments on 3 draft IDLH values and IDLH Value
Profiles. The draft IDLH Value Profiles were developed to provide the
scientific rationale behind derivation of IDLH values for the following
chemicals:
------------------------------------------------------------------------
Document No. Chemical CAS No.
------------------------------------------------------------------------
C-01.......................... Bromine Trifluoride.. (7787-71-5)
C-02.......................... Chlorine Trifluoride. (7790-91-2)
C-03.......................... Ethylene Dibromide... (106-93-4)
------------------------------------------------------------------------
Each IDLH Value Profile provides a detailed summary of the health
hazards of acute exposures to high airborne concentrations and the
rationale for the proposed IDLH value with the chemical(s) of interest.
Background: In 2013, NIOSH published Current Intelligence Bulletin
(CIB) 66--Derivation of Immediately Dangerous to Life or Health (IDLH)
Values [NIOSH 2013]. Since the establishment of the IDLH values in the
1970s, NIOSH has continued to review available scientific data to
improve the protocol used to derive acute exposure guidelines, in
addition to the chemical-specific IDLH values. The information
presented in this CIB represents the most recent update of the
scientific rationale and the methodology (hereby referred to as the
IDLH methodology) used to derive IDLH values. The primary objectives of
this document are to:
1. Provide a brief history of the development of IDLH values.
2. Update the scientific bases and risk assessment methodology used
to derive IDLH values from quality data.
3. Provide transparency behind the rationale and derivation process
for IDLH values.
4. Demonstrate how scientifically credible IDLH values can be
derived from available data resources.
The IDLH methodology is based on a weight-of-evidence approach that
applies scientific judgment for critical evaluation of the quality and
consistency of scientific data and in extrapolation from the available
data to the IDLH value. The weight-of-evidence approach refers to
critical examination of all available data from diverse lines of
evidence and the derivation of a scientific interpretation on the basis
of the collective body of data, including its relevance, quality, and
reported results. Conceptually, the derivation process for IDLH values
is similar to that used in other risk-assessment applications,
including these steps:
1. Hazard characterization.
2. Identification of critical adverse effects.
3. Identification of a POD.
4. Application of appropriate UFs, based on the study and POD.
5. Determination of the final risk value.
Reference
NIOSH [2013]. Current Intelligence Bulletin 66: Derivation of
immediately dangerous to life or health (IDLH) values. Cincinnati,
OH: U.S. Department of Health and Human Services, Centers for
Disease Control and Prevention, National Institute for Occupational
Safety and Health, DHHS (NIOSH) Publication 2014-100.
Dated: June 5, 2018.
John J. Howard,
Director, National Institute for Occupational Safety and Health,
Centers for Disease Control and Prevention.
[FR Doc. 2018-12364 Filed 6-7-18; 8:45 am]
BILLING CODE 4163-19-P
